Caryn G. McDowell
Plus aucun poste en cours
Fortune : 271 148 $ au 31/03/2024
Profil
Caryn G.
McDowell formerly worked at Affymax, Inc., as Executive Director-Corporate Law from 2012 to 2013, Onyx Pharmaceuticals, Inc., as Associate General Counsel & Head-US Healthcare Law in 2013, InterMune, Inc., as SVP, Deputy General Counsel & Assistant Secretary from 2014 to 2015, Cytokinetics, Inc., as Chief Compliance Officer & General Counsel from 2016 to 2018, Revance Therapeutics, Inc., as Secretary, Senior VP & General Counsel, State of Massachusetts, as Assistant Attorney General-Medicaid Fraud Control, US Department of Health & Human Services (DC), as Senior Counsel-Inspector General Office from 2001 to 2004, and Quince Therapeutics, Inc., as Secretary, Chief Administrative & Legal Officer from 2020 to 2022.
Ms. McDowell received her undergraduate degree from the University of Michigan and graduate degree from Boston University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2023 | 255 800 ( 0,60% ) | 271 148 $ | 31/03/2024 |
Anciens postes connus de Caryn G. McDowell
| Sociétés | Poste | Fin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Administrative Officer | 08/07/2022 |
| CYTOKINETICS, INCORPORATED | Compliance Officer | 01/05/2018 |
| INTERMUNE INC | Corporate Officer/Principal | 01/02/2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | General Counsel | 01/12/2013 |
| AFFYMAX, INC. | General Counsel | 01/01/2013 |
Formation de Caryn G. McDowell
| University of Michigan | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| AFFYMAX, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
| State of Massachusetts | Government |
| US Department of Health & Human Services (DC) | Government |
